antibacterial drug development

Avarofloxacin (JNJ-Q2) is a broad-spectrum fluoroquinolone antibacterial drug being developed for the treatment of acute bacterial skin and community-acquired pneumonia and skin structure infections.

Ga(III)protoporphyrin-IX, a model for interporphyrin interactions in malaria pigment, possesses potent antibacterial effects against gram-negative, gram-positive, and acid-fast bacteria. It exhibits high solubility in methanol (MeOH) and serves as a malarial pigment analogue for drug development, as well as a potential antibacterial agent.

Antibacterial agent 126 是一种有效的抗菌剂。Antibacterial agent 126 扰乱膜完整性并导致细胞内物质渗漏。Antibacterial agent 126 减少生物膜的负担，避免产生耐药性。Antibacterial agent 126 增加 ROS 和活性氮物质 (RNS) 的产生。